News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
As Primate Research Drops in Europe, Overseas Options Appeal
Katarina Zimmer | Aug 21, 2018
A combination of public opposition, intense regulations, and rising costs in the EU make conditions in China and elsewhere attractive for studying monkeys.
A Record Year for Measles Cases in Europe
Shawna Williams | Aug 21, 2018
The WHO reports more than 41,000 cases in the region in the first half of 2018.
Definitive Evidence for Water Ice on the Moon: Study
Ashley Yeager | Aug 21, 2018
Data from the Indian Space Research Organization’s Chandrayaan 1 spacecraft show frost on the lunar north and south poles.
University of Florida Culled 150 Birds to Protect Research Plots
Sukanya Charuchandra | Aug 20, 2018
Officials say the birds had eaten crops meant for experiments.
Opinion: The Value of Collaborations in the Emerging and Developing World
Mohamed Boudjelal | Aug 20, 2018
Scientists can foster new talent, find new funding options, and tap into business opportunities by forging relationships between researchers in emerging, developing and developed nations.
Dartmouth Professor Plagiarized His Colleague, University Says
Jef Akst | Aug 20, 2018
H. Gilbert Welch, a health policy expert who has advocated against superfluous cancer screening, published another Dartmouth researcher’s work, according to the university administration.
Randy Schekman to Leave
Kerry Grens | Aug 19, 2018
The founding editor-in-chief will redirect his focus to a Parkinson’s organization.
NYU Medical School Is Now Free, Almost
Shawna Williams | Aug 17, 2018
All students’ tuition will be funded through its endowment.
Synthetic Bacteria Help Treat Phenylketonuria in Mice
Diana Kwon | Aug 17, 2018
The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.
Drug Approval Could Boost Research on Marijuana Treatment for Autism
Jessica Wright | Aug 17, 2018
Epidiolex, a cannabis-derived medicine for epilepsy, will prompt federal regulatory changes that could crack open access to study the plant.